Pathway analysis, which included all genes associated with the HIF1A pathway according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) [ 27] revealed no significant changes in pathway expression in tumor and before and after treatment with metformin (Fig. 4a and b). This evidence concerns the gene HIF1A and neoplasm.